Skip to main content
Toggle navigation
Search
Home
Preview Program
Browse by Speaker
Home
Browse by Speaker
Browse by Speaker
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
W
Wakeman, Sarah
Mass General Brigham
Annual Review of Addiction Medicine: Highest Impact Publications from 2024-2025
Location: Colorado Ballroom, Level 3
Sarah Wakeman
General Session - The Science of GLP-1 Receptor Agonists: A Rising Tide in Addiction Treatment
Location: Colorado Ballroom, Level 3
Sarah Wakeman
Walley, Alexander
Boston University Chobanian & Avedisian School of Medicine
Developing Addiction Medicine Fellowships
Location: Aurora Ballroom A, Level 2
Alexander Walley
Harm Reduction is Healthcare: Decreasing Risk and Stigma With People Who Use Drugs
Location: Aurora Ballroom B, Level 2
Alexander Walley
Ware, Orrin
University of North Carolina at Chapel Hill
From Submission to Success: Insider Tips for Getting Your Addiction Content Published
Location: Aurora Ballroom B, Level 2
Orrin Ware
Warshaw, Carole
National Center on Domestic Violence, Trauma, and Mental Healtth
Navigating Substance Use Coercion: Practical Tools for Screening and Intervention
Location: Willow Lake 3-5, Level 3
Carole Warshaw
Weaver, Michael
The University of Texas Health Science Center at Houston
Addiction Medicine and the Law: How to Become an Expert Witness
Location: Crest 3-5, Level 2
Michael Weaver
Becoming Certified in Addiction Medicine and How to Continue That Certification
Location: Aurora Ballroom D, Level 2
Michael Weaver
Heavy Hitters: Glucagon-like Peptide-1 (GLP-1) Receptor Agonists for Addiction Treatment
Location: Aurora Ballroom B, Level 2
Michael Weaver
Weimer, Melissa
Yale School of Medicine
Innovative Buprenorphine Initiation Strategies
Location: Aurora Ballroom A, Level 2
Melissa Weimer
Weisenthal, Karrin
Boston Medical Center
Harm Reduction is Healthcare: Decreasing Risk and Stigma With People Who Use Drugs
Location: Aurora Ballroom B, Level 2
Karrin Weisenthal
Weiss, Isabella
Los Angeles County Department of Public Health, Substance Abuse Prevention and Control Bureau
Redesigning Specialty Substance Use Disorder Systems to Better Reach the 95%
Location: Aurora Ballroom A, Level 2
Isabella Weiss
Weiss, Stephanie
National Institute on Drug Abuse Intramural Research Program
Complexities and Controversies in Assessing, Diagnosing, and Managing Kratom Use
Location: Aurora Ballroom A, Level 2
Stephanie Weiss
General Session - The Science of GLP-1 Receptor Agonists: A Rising Tide in Addiction Treatment
Location: Colorado Ballroom, Level 3
Stephanie Weiss
Wenzel, Kevin
Maryland Treatment Centers
Improving Outcomes for Youth OUD Treatment
Location: Red Rock 8-9, Level 3
Kevin Wenzel
Wiegand, Timothy
Strong Memorial Hospital
Addiction Medicine and the Law: How to Become an Expert Witness
Location: Crest 3-5, Level 2
Timothy Wiegand
Management of Benzodiazepine Withdrawal in the Outpatient and Non-Hospital Settings
Location: Aurora Ballroom A, Level 2
Timothy Wiegand
Wightman, Rachel
Brown University
Emerging Illicit Substances: What Clinicians Need to Know
Location: Colorado Ballroom, Level 3
Rachel Wightman
Wilkoff, Hannah
University of Maryland School of Pharmacy
Injectable Medications for Addiction: Hands-On Practice for Providers
Room Capacity Limited to 150
Location: Aurora Ballroom B, Level 2
Hannah Wilkoff
Injectable Medications for Addiction: Hands-On Practice for Providers
Room Capacity Limited to 150
Location: Aurora Ballroom B, Level 2
Hannah Wilkoff
Williams, Maggie
UW Health
How Low Can you go? Low Barrier Buprenorphine Care Delivery Models
Location: Colorado Ballroom, Level 3
Maggie Williams
Wolinsky, David
Department of Psychiatry and Behavioral Sciences at the Johns Hopkins School of Medicine
Innovative Buprenorphine Initiation Strategies
Location: Aurora Ballroom A, Level 2
David Wolinsky
Wright, Tricia
University of California, San Francisco
Safe Tapering of Benzodiazepines: Insights from Joint Clinical Practice Guideline
Location: Aurora Ballroom A, Level 2
Tricia Wright
